
Sign up to save your podcasts
Or


A promising new experimental medication for PKD is generating a lot of excitement — and for good reason. In this research review episode, Diana breaks down what Farabursen is, how it works at the genetic level, and why targeting microRNA may help increase polycystin protein production and potentially halt cyst growth.
If you want a science-backed look at where PKD treatment may be headed — this episode is for you!
You’ll learn a simple explanation of DNA, genes, and protein signaling, what early studies are showing so far, what phase 3 trials may look like, and who may qualify to participate.
RESOURCES & LINKS
DISCLAIMER: The PKD Dietitian Podcast is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.
By Diana Bruen MS, RDA promising new experimental medication for PKD is generating a lot of excitement — and for good reason. In this research review episode, Diana breaks down what Farabursen is, how it works at the genetic level, and why targeting microRNA may help increase polycystin protein production and potentially halt cyst growth.
If you want a science-backed look at where PKD treatment may be headed — this episode is for you!
You’ll learn a simple explanation of DNA, genes, and protein signaling, what early studies are showing so far, what phase 3 trials may look like, and who may qualify to participate.
RESOURCES & LINKS
DISCLAIMER: The PKD Dietitian Podcast is for educational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment.